Process for producing aplha-1,3-glucan polymer with reduced molecular weight

ABSTRACT

A process for producing poly alpha-1,3-glucan with reduced molecular weight is disclosed. The process comprises contacting water, sucrose, a polar organic solvent, and a glucosyltransferase enzyme in a solution to produce poly alpha-1,3-glucan. This contacting step results in the production of poly alpha-1,3-glucan having a reduced molecular weight compared to the molecular weight of a poly alpha-1,3-glucan made in the absence of the polar organic solvent.

This application claims the benefit of U.S. Provisional Application No.61/873,851, filed Sep. 5, 2013, which is incorporated herein byreference in its entirety.

FIELD OF THE INVENTION

This invention is in the field of enzymatic processes. Specifically,this invention pertains to a process for producing alpha-1,3-glucanpolymer in a solution comprising glucosyl transferase, sucrose, and apolar organic solvent.

REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY

The official copy of the sequence listing is submitted electronicallyvia EFS-Web as an ASCII formatted sequence listing with a file namedCL5841 USNP_SequenceListing.txt created on Sep. 3, 2014, and having asize of 259 kilobytes and is filed concurrently with the specification.The sequence listing contained in this ASCII-formatted document is partof the specification and is herein incorporated by reference in itsentirety.

BACKGROUND OF THE INVENTION

Cellulose, a polysaccharide consisting of beta-1,4-linked glucose formedby natural processes (Applied Fiber Science, F. Happey, Ed., Chapter 8,E. Atkins, Academic Press, New York, 1979), has become the preeminentfiber for use in manufactured textiles, films and resins.

Cellulose and starch exhibit properties that are determined by thenature of their linkage pattern. Starch or amylose consisting ofalpha-1,4 linked glucose are not useful for fiber applications becauseit is swollen or dissolved by water. Cellulose, on the other hand, has abeta-1,4 linkage which provides the crystalline and hydrophobicqualities making cellulose a good structural material. Thus, celluloseis commonly used for textile applications like cotton fiber.

Cellulosic fibers such as cotton and rayon increasingly presentsustainability issues with respect to land use and environmentalimprint. This may be a significant factor leading to increased level ofresearch into textiles containing polyester fiber blends with cellulosicmaterials and more sustainable alternatives for cellulosic-derivedmaterials.

Driven by a desire to find new structural polysaccharides usingenzymatic syntheses or genetic engineering of microorganisms or planthosts, researchers have discovered polysaccharides that arebiodegradable, and that can be made economically from renewableresource-based feedstocks. One such polysaccharide is polyalpha-1,3-glucan, a glucan polymer characterized by havingalpha-1,3-glycosidic linkages. This polymer has been isolated bycontacting an aqueous solution of sucrose with a glucosyltransferaseenzyme isolated from Streptococcus salivarius (Simpson et al.,Microbiology 141:1451-1460, 1995). Films prepared from polyalpha-1,3-glucan tolerate temperatures up to 150° C. and provide anadvantage over polymers obtained from beta-1,4-linked polysaccharides(Ogawa et al., Fiber Differentiation Methods 47:353-362, 1980).

U.S. Pat. No. 7,000,000 disclosed the preparation of a polysaccharidefiber comprising hexose units, wherein at least 50% of the hexose unitswithin the polymer were linked via alpha-1,3-glycosidic linkages usingan S. salivarius gtfJ enzyme. This enzyme utilizes sucrose as asubstrate in a polymerization reaction producing poly alpha-1,3-glucanand fructose as end-products (Simpson et al., 1995).

The production of poly alpha-1,3-glucan for commercial applicationsusing sucrose and gtf enzymes requires a high yield process thatproduces minimal amounts of by-product such as leucrose as well as theability to control the polymer length or molecule weight of theresulting poly alpha-1,3-glucan.

Castillo et al. (Journal of Biotechnology 114:209-217, 2004) disclosedthat the inclusion of 2-methyl-2-propanol (tert-butyl alcohol) in areaction for producing levan resulted in levan having an increasedmolecular weight profile compared to the molecular weight profile oflevan made without using tert-butyl alcohol.

Masanori et al. (Japanese Pat. Appl. Publ. No. P2000-175694A) disclosedthat the inclusion of dimethyl sulfoxide in a reaction for producingmutan resulted in the production of mutan with increased molecularweight compared to the molecular weight observed in reactions lackingdimethyl sulfoxide. Thus, increasing the molecular weight of certainpolysaccharide polymers is possible under certain reaction conditions.

Alternatively, decreasing the molecular weight of polysaccharidepolymers is another means by which to control the molecular weight.Accordingly, processes for producing poly alpha-1,3-glucan havingreduced molecular weight are desirable as another approach to producinga polysaccharide polymer of desired molecular weight.

SUMMARY OF THE INVENTION

In one embodiment, the invention concerns a process for producing polyalpha-1,3-glucan comprising contacting water, sucrose, a polar organicsolvent, and a glucosyltransferase enzyme in a solution, wherein theglucosyltransferase enzyme synthesizes poly alpha-1,3-glucan. The polyalpha-1,3-glucan thus produced has a reduced molecular weight comparedto the molecular weight of a poly alpha-1,3-glucan that would beproduced in the absence of the polar organic solvent. Optionally, theprocess in this embodiment further comprises the step of isolating thepoly alpha-1,3-glucan produced in the contacting step.

In a second embodiment, the polar organic solvent is aprotic. Theaprotic polar organic solvent can be acetonitrile, dimethyl sulfoxide,acetone, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran,propylene carbonate, or sulfolane, for example.

In a third embodiment, the polar organic solvent is protic. The proticpolar organic solvent can be methanol, methyl formamide, ethanol,isopropanol, 1-propanol, tert-butyl alcohol, or formamide, for example.

In a fourth embodiment, the concentration of the polar organic solventin the solution is about 2% to about 20% by volume. In a fifthembodiment, the concentration of the polar organic solvent in thesolution is about 10% by volume.

In a sixth embodiment, the solution has a temperature between about 5°C. to about 50° C.

In a seventh embodiment, the initial concentration of the sucrose in thesolution is about 20 g/L to about 400 g/L.

In an eighth embodiment, the molecular weight of the polyalpha-1,3-glucan produced in the contacting step is reduced by at leastabout 15%. In a ninth embodiment, the molecular weight of the polyalpha-1,3-glucan produced in the contacting step is reduced by at leastabout 50%.

In a tenth embodiment, the molecular weight is measured as weightaverage degree of polymerization (DPw). In an eleventh embodiment, theDPw of the poly alpha-1,3-glucan produced in the contacting step isbetween about 40 and 800.

In a twelfth embodiment, the glucosyltransferase enzyme is a bacterialglucosyltransferase enzyme.

In a thirteenth embodiment, the glucosyltransferase enzyme comprises anamino acid sequence that is at least 90% identical to SEQ ID NO:12, SEQID NO:2, or SEQ ID NO:32.

BRIEF DESCRIPTION OF THE SEQUENCES

TABLE 1 Summary of Nucleic Acid and Protein SEQ ID Numbers Nucleic acidProtein Description SEQ ID NO. SEQ ID NO. “gtfJ”, Streptococcussalivarius. DNA codon- 1  2 optimized for expression in E. coli. Thefirst 42 amino (1477 aa) acids of the protein are deleted compared toGENBANK Identification No. 47527; a start methionine is included. “0874gtf”, Streptococcus sobrinus. DNA codon- 3  4 optimized for expressionin E. coli. The first 156 (1435 aa) amino acids of the protein aredeleted compared to GENBANK Identification No. 450874; a startmethionine is included. “2678 gtf”, Streptococcus salivarius K12. DNAcodon- 5  6 optimized for expression in E. coli. The first 188 (1341 aa)amino acids of the protein are deleted compared to GENBANKIdentification No. 400182678; a start methionine is included. “2919gtf”, Streptococcus salivarius PS4. DNA 7  8 codon-optimized forexpression in E. coli. The first 92 (1340 aa) amino acids of the proteinare deleted compared to GENBANK Identification No. 383282919; a startmethionine is included. “5926 gtf”, Streptococcus dentirousetti. DNAcodon- 9 10 optimized for expression in E. coli. The first 144 (1323 aa)amino acids of the protein are deleted compared to GENBANKIdentification No. 167735926; a start methionine is included. “6855gtf”, Streptococcus salivarius SK126. DNA 11 12 codon-optimized forexpression in E. coli. The first (1341 aa) 178 amino acids of theprotein are deleted compared to GENBANK Identification No. 228476855; astart methionine is included. “gtfJ-T1”, Streptococcus salivarius. Thefirst 230 13 14 amino acids and the last 384 amino acids of the  (905aa) protein are deleted compared to GENBANK Identification No. 47527; astart methionine is included. “5926-T1”, Streptococcus dentirousetti.The first 199 15 16 amino acids and the last 417 amino acids of the (851 aa) protein are deleted compared to GENBANK Identification No.167735926; a start methionine is included. “wild type gtfJ”,Streptococcus salivarius. GENBANK 17 18 Identification No. 47527. (1518aa) “2379 gtf”, Streptococcus salivarius. DNA codon- 19 20 optimized forexpression in E. coli. The first 203 (1247 aa) amino acids of theprotein are deleted compared to GENBANK Identification No. 662379; astart methionine is included. “1724 gtf”, Streptococcus downei. DNAcodon- 21 22 optimized for expression in E. coli. The first 162 (1436aa) amino acids of the protein are deleted compared to GENBANKIdentification No. 121724; a start methionine is included. “0544 gtf”,Streptococcus mutans. DNA codon- 23 24 optimized for expression in E.coli. The first 164 (1313 aa) amino acids of the protein are deletedcompared to GENBANK Identification No. 290580544; a start methionine isincluded. “4297 gtf”, Streptococcus oralis. DNA codon- 25 26 optimizedfor expression in E. coli. The first 228 (1348 aa) amino acids of theprotein are deleted compared to GENBANK Identification No. 7684297; astart methionine is included. “5618 gtf”, Streptococcus sanguinis. DNAcodon- 27 28 optimized for expression in E. coli. The first 223 (1348aa) amino acids of the protein are deleted compared to GENBANKIdentification No. 328945618; a start methionine is included. “2765gtf”, unknown Streptococcus sp. C150. DNA 29 30 codon-optimized forexpression in E. coli. The first (1340 aa) 193 amino acids of theprotein are deleted compared to GENBANK Identification No. 322372765; astart methionine is included. Streptococcus salivarius gtfJ. The first177 amino 31 32 acids of the protein are deleted compared to (1342 aa)GENBANK Identification No. 47527; a start methionine is included.

DETAILED DESCRIPTION OF THE INVENTION

The disclosures of all patent and non-patent literature cited herein areincorporated herein by reference in their entirety.

As used herein, the term “invention” or “disclosed invention” is notmeant to be limiting, but applies generally to any of the inventionsdefined in the claims or described herein. These terms are usedinterchangeably herein.

The terms “poly alpha-1,3-glucan”, “alpha-1,3-glucan polymer” and“glucan polymer” are used interchangeably herein. Poly alpha-1,3-glucanis a polymer comprising glucose monomeric units linked together byglycosidic linkages, wherein at least about 50% of the glycosidiclinkages are alpha-1,3-glycosidic linkages. Poly alpha-1,3-glucan is atype of polysaccharide. The structure of poly alpha-1,3-glucan can beillustrated as follows:

The terms “glycosidic linkage” and “glycosidic bond” are usedinterchangeably herein and refer to the type of covalent bond that joinsa carbohydrate (sugar) molecule to another group such as anothercarbohydrate. The term “alpha-1,3-glycosidic linkage” as used hereinrefers to the type of covalent bond that joins alpha-D-glucose moleculesto each other through carbons 1 and 3 on adjacent alpha-D-glucose rings.This linkage is illustrated in the poly alpha-1,3-glucan structureprovided above. Herein, “alpha-D-glucose” will be referred to as“glucose”.

The term “sucrose” herein refers to a non-reducing disaccharide composedof an alpha-D-glucose molecule and a beta-D-fructose molecule linked byan alpha-1,2-glycosidic bond. Sucrose is known commonly as table sugar.

The “molecular weight” of the poly alpha-1,3-glucan herein can berepresented by various measures such as grams/mole, Daltons, DPw(“weight average degree of polymerization”) and DPn (“number averagedegree of polymerization”). Various means are known in the art forcalculating these molecular weight measurements.

The terms “glucosyltransferase enzyme that synthesizes polyalpha-1,3-glucan”, “glucosyltransferase enzyme”, “gtf enzyme”, “gtf”,and “glucansucrase” are used interchangeably herein. The activity of agtf enzyme herein catalyzes the reaction of the substrate sucrose tomake the products poly alpha-1,3-glucan and fructose. Other products(byproducts) of a gtf reaction can include glucose (where glucose ishydrolyzed from the glucosyl-gtf enzyme intermediate complex), varioussoluble oligosaccharides (DP2-DP7), and leucrose (where glucose of theglucosyl-gtf enzyme intermediate complex is linked to fructose).Leucrose is a disaccharide composed of glucose and fructose linked by analpha-1,5 linkage. Wild type forms of glucosyltransferase enzymesgenerally contain (in the N-terminal to C-terminal direction) a signalpeptide, a variable domain, a catalytic domain, and a glucan-bindingdomain.

The terms “reaction” and “enzymatic reaction” are used interchangeablyherein and refer to a reaction that is catalyzed by aglucosyltransferase enzyme. A “reaction solution” as used hereingenerally refers to a solution comprising at least one activeglucosyltransferase enzyme in a buffer solution comprising sucrose,water, and optionally a polar organic solvent. It is in the reactionsolution where the step of contacting water, sucrose, a polar organicsolvent, and a glucosyltransferase enzyme is performed. The term “undersuitable reaction conditions” as used herein, refers to reactionconditions supporting the conversion of sucrose to poly alpha-1,3-glucanusing a glucosyltransferase enzyme.

The terms “polar organic solvent” and “water-miscible organic solvent”are used interchangeably herein. A polar organic solvent can bedissolved in water or an aqueous solution. Thus, a polar organic solventdoes not separate out into a different phase when added to water or anaqueous solution. A polar organic solvent contains carbon and at leastone heteroatom (i.e., non-carbon or—hydrogen atom) such as oxygen,nitrogen, sulfur, or phosphorous. This contrasts with non-polar organicsolvents, which generally comprise only carbon and hydrogen atoms. Apolar organic solvent typically has a dielectric constant greater thanabout 4. Polar organic solvents contain dipoles due to polar bonds. Incertain embodiments, the polar organic solvent dissolves in water or anaqueous solution at a temperature between about 5° C. to 50° C.

The term “aprotic polar organic solvent” herein refers to a polarorganic solvent that does not have suitably labile hydrogen atoms thatcan form hydrogen bonds. An aprotic polar organic solvent does notcontain hydrogen atoms bonded to an atom with electronegative character;e.g., there are no O—H, N—H, or S—H bonds.

The term “protic polar organic solvent” herein refers to a polar organicsolvent that has one or more suitably labile hydrogen atoms that can toform hydrogen bonds. A protic polar organic solvent generally containshydrogen atoms bonded to an atom with electronegative character; e.g.,there are O—H, N—H, and/or S—H bonds.

The terms “percent by volume”, “volume percent”, “vol %” and “v/v %” areused interchangeably herein. The percent by volume of a solute in asolution can be determined using the formula: [(volume ofsolute)/(volume of solution)]×100%.

The terms “percent by weight”, “weight percentage (wt %)” and“weight-weight percentage (% w/w)” are used interchangeably herein.Percent by weight refers to the percentage of a material on a mass basisas it is comprised in a composition, mixture or solution.

The terms “polynucleotide”, “polynucleotide sequence”, and “nucleic acidsequence” are used interchangeably herein. These terms encompassnucleotide sequences and the like. A polynucleotide may be a polymer ofDNA or RNA that is single- or double-stranded, that optionally containssynthetic, non-natural or altered nucleotide bases. A polynucleotide maybe comprised of one or more segments of cDNA, genomic DNA, syntheticDNA, or mixtures thereof.

The term “gene” as used herein refers to a polynucleotide sequence thatexpresses a protein, and which may refer to the coding region alone ormay include regulatory sequences upstream and/or downstream to thecoding region (e.g., 5′ untranslated regions upstream of thetranscription start site of the coding region). A gene that is “native”or “endogenous” refers to a gene as found in nature with its ownregulatory sequences; this gene is located in its natural location inthe genome of an organism. “Chimeric gene” refers to any gene that isnot a native gene, comprising regulatory and coding sequences that arenot found together in nature. A “foreign” or “heterologous” gene refersto a gene that is introduced into the host organism by gene transfer.Foreign genes can comprise native genes inserted into a non-nativeorganism, native genes introduced into a new location within the nativehost, or chimeric genes. The polynucleotide sequences in certainembodiments disclosed herein are heterologous. A “transgene” is a genethat has been introduced into the genome by a transformation procedure.A “codon-optimized gene” is a gene having its frequency of codon usagedesigned to mimic the frequency of preferred codon usage of the hostcell.

A native amino acid sequence or polynucleotide sequence is naturallyoccurring, whereas a non-native amino acid sequence or polynucleotidesequence does not occur in nature.

“Coding sequence” as used herein refers to a DNA sequence that codes fora specific amino acid sequence. “Regulatory sequences” as used hereinrefer to nucleotide sequences located upstream of the coding sequence'stranscription start site, 5′ untranslated regions and 3′ non-codingregions, and which may influence the transcription, RNA processing orstability, or translation of the associated coding sequence. Regulatorysequences may include promoters, enhancers, silencers, 5′ untranslatedleader sequence, introns, polyadenylation recognition sequences, RNAprocessing sites, effector binding sites, stem-loop structures and otherelements involved in regulation of gene expression.

The term “recombinant” as used herein refers to an artificialcombination of two otherwise separated segments of sequence, e.g., bychemical synthesis or by the manipulation of isolated segments ofnucleic acids by genetic engineering techniques. The terms“recombinant”, “transgenic”, “transformed”, “engineered” or “modifiedfor exogenous gene expression” are used interchangeably herein.

The term “transformation” as used in certain embodiments refers to thetransfer of a nucleic acid molecule into a host organism. The nucleicacid molecule may be a plasmid that replicates autonomously, or it mayintegrate into the genome of the host organism. Host organismscontaining the transformed nucleic acid fragments are referred to as“transgenic” or “recombinant” or “transformed” organisms or“transformants”.

The term “recombinant” or “heterologous” refers to an artificialcombination of two otherwise separated segments of sequence, e.g., bychemical synthesis or by the manipulation of isolated segments ofnucleic acids by genetic engineering techniques.

The terms “sequence identity” or “identity” as used herein with respectto polynucleotide or polypeptide sequences refer to the nucleic acidbases or amino acid residues in two sequences that are the same whenaligned for maximum correspondence over a specified comparison window.Thus, “percentage of sequence identity” or “percent identity” refers tothe value determined by comparing two optimally aligned sequences over acomparison window, wherein the portion of the polynucleotide orpolypeptide sequence in the comparison window may comprise additions ordeletions (i.e., gaps) as compared to the reference sequence (which doesnot comprise additions or deletions) for optimal alignment of the twosequences. The percentage is calculated by determining the number ofpositions at which the identical nucleic acid base or amino acid residueoccurs in both sequences to yield the number of matched positions,dividing the number of matched positions by the total number ofpositions in the window of comparison and multiplying the results by 100to yield the percentage of sequence identity.

The Basic Local Alignment Search Tool (BLAST) algorithm, which isavailable online at the National Center for Biotechnology Information(NCBI) website, may be used, for example, to measure percent identitybetween or among two or more of the polynucleotide sequences (BLASTNalgorithm) or polypeptide sequences (BLASTP algorithm) disclosed herein.Alternatively, percent identity between sequences may be performed usinga Clustal algorithm (e.g., ClustalW or ClustalV). For multiplealignments using a Clustal method of alignment, the default values maycorrespond to GAP PENALTY=10 and GAP LENGTH PENALTY=10. Defaultparameters for pairwise alignments and calculation of percent identityof protein sequences using a Clustal method may be KTUPLE=1, GAPPENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. For nucleic acids, theseparameters may be KTUPLE=2, GAP PENALTY=5, WINDOW=4 and DIAGONALSSAVED=4.

Various polypeptide amino acid sequences and polynucleotide sequencesare disclosed herein as features of certain embodiments of the disclosedinvention. Variants of these sequences that are at least about 70-85%,85-90%, or 90%-95% identical to the sequences disclosed herein may beused in certain embodiments. Alternatively, a variant amino acidsequence or polynucleotide sequence in certain embodiments can have atleast 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%,83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%,97%, 98% or 99% identity with a sequence disclosed herein. The variantamino acid sequence or polynucleotide sequence has the samefunction/activity of the disclosed sequence, or at least about 85%, 86%,87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% ofthe function/activity of the disclosed sequence.

The term “isolated” as used in certain embodiments refers to anycellular component that has been completely or partially purified fromits native source (e.g., an isolated polynucleotide or polypeptidemolecule). In some instances, an isolated polynucleotide or polypeptidemolecule is part of a greater composition, buffer system or reagent mix.For example, the isolated polynucleotide or polypeptide molecule can becomprised within a cell or organism in a heterologous manner. Anotherexample is an isolated glucosyltransferase enzyme.

Embodiments of the disclosed invention concern a process for producingpoly alpha-1,3-glucan that comprises contacting water, sucrose, a polarorganic solvent, and a glucosyltransferase enzyme that synthesizes polyalpha-1,3-glucan in solution, wherein a poly alpha-1,3-glucan isproduced that has a reduced molecular weight compared to the molecularweight of a poly alpha-1,3-glucan that would be produced in the absenceof the polar organic solvent. The poly alpha-1,3-glucan produced by thereaction solution can optionally be isolated. Significantly, thisprocess avoids the complexities of introducing enzyme and/or temperaturemodifications in trying to reduce the molecular weight of polyalpha-1,3-glucan produced by reactions catalyzed by glucosyltransferaseenzyme.

This process can alternatively be characterized as synthesizing polyalpha-1,3 glucan from a reaction solution comprising water, sucrose, apolar organic solvent, and a glucosyltransferase enzyme, whereby polyalpha-1,3-glucan is produced that has a reduced molecular weightcompared to poly alpha-1,3-glucan that would be produced if the polarorganic solvent is not present in the reaction solution.

One of ordinary skill in the art would appreciate that a reactionsolution in which there is no added polar organic solvent (pure aqueous)can be a control reaction with respect to the process of the inventiondisclosed herein. The control reaction in certain embodiments can havecomparable features except for the presence of a polar organic solvent(i.e., the only variable is the presence of a polar organic solvent).

The molecular weight of poly alpha-1,3-glucan made by the process of theinvention is reduced by at least about 15% in certain embodiments. Inother embodiments, the molecular weight of the poly alpha-1,3-glucanproduced by the process of the invention is reduced by at least about50%. Alternatively, the molecular weight of the poly alpha-1,3-glucanproduced in the process can be reduced by at least about 5%, 10%, 15%,20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, or 70% (or any integerbetween 5% and 70%). The reduced molecular weight can be expressed interms of the DPw of the produced poly alpha-1,3-glucan. The process ofthe invention does not produce poly alpha-1,3-glucan having an increasedmolecular weight, when expressed in terms of DPw for example.

The molecular weight of the poly alpha-1,3-glucan produced by theinstant process can be measured as DPw (weight average degree ofpolymerization). Alternatively, the molecular weight of the polyalpha-1,3-glucan produced by the instant process can be measured interms of Daltons, grams/mole, or as DPn (number average degree ofpolymerization). The molecular weight of poly alpha-1,3-glucan producedby the instant process can be measured in DPw and is between about 40and 800, for example. The DPw of the poly alpha-1,3-glucan produced inthe process can alternatively be between about 100-200, 100-300,100-400, 100-500, 100-600, 100-700, 100-800, 200-300, 200-400, 200-500,200-600, 200-700, 200-800, 300-400, 300-500, 300-600, 300-700, 300-800,400-500, 400-600, 400-700, 400-800, 500-600, 500-700, 500-800, 600-700,600-800, or 700-800.

The poly alpha-1,3-glucan produced by the process of the instantinvention is preferably linear/unbranched. The percentage of glycosidiclinkages between the glucose monomer units of the poly alpha-1,3-glucanthat are alpha-1,3 is at least about 50%, 60%, 70%, 80%, 90%, 95%, 96%,97%, 98%, 99%, or 100%. In such embodiments, accordingly, the polyalpha-1,3-glucan has less than about 50%, 40%, 30%, 20%, 10%, 5%, 4%,3%, 2%, 1%, or 0% (or any integer between 0% and 50%) of glycosidiclinkages that are not alpha-1,3. Examples of such non-alpha-1,3glycosidic linkages include, but are not limited to, beta linkages(e.g., beta-1,2; beta-1,3; beta-1,4; beta-1,6) and other alpha linkages(e.g., alpha-1,2; alpha-1,4; alpha-1,6).

It is understood that the higher the percentage of alpha-1,3-glycosidiclinkages present in the poly alpha-1,3-glucan, the greater theprobability that the poly alpha-1,3-glucan is linear, since there arelower occurrences of certain glycosidic linkages forming branch pointsin the polymer. In certain embodiments, the poly alpha-1,3-glucan has nobranch points or less than about 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or1% branch points as a percent of the glycosidic linkages in the polymer.Examples of branch points include alpha-1,6 branch points, such as thosethat are present in mutan polymer.

The glycosidic linkage profile of the poly alpha-1,3-glucan can bedetermined using any method known in the art. For example, the linkageprofile can be determined using methods that use nuclear magneticresonance (NMR) spectroscopy (e.g., ¹³C NMR or ¹H NMR). These and othermethods that can be used are disclosed in Food Carbohydrates: Chemistry,Physical Properties, and Applications (S. W. Cui, Ed., Chapter 3, S. W.Cui, Structural Analysis of Polysaccharides, Taylor & Francis Group LLC,Boca Raton, Fla., 2005), which is incorporated herein by reference.

The poly alpha-1,3-glucan produced in the disclosed process can beeither soluble or insoluble in most aqueous systems, where insolublepolymer is preferred. In general, the solubility of a glucan polymer inmost aqueous systems is related to its linkage type, molecular weightand/or degree of branching. Poly alpha-1,3-glucan is generally insolubleat a DPw of 8 and above in aqueous (or mostly aqueous) solutions at 20°C.

The molecular weight of the poly alpha-1,3-glucan produced by theprocess of the present invention can be measured using any of severalmeans known in the art. For example, glucan polymer molecular weight canbe measured using high-pressure liquid chromatography (HPLC), sizeexclusion chromatography (SEC), or gel permeation chromatography (GPC).

The yield of the poly alpha-1,3-glucan produced in the disclosed processcan be at least about 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,16%, 17%, 18%, 19%, or 20%, based on the weight of the sucrose used inthe process.

The process of the invention comprises contacting a glucosyltransferaseenzyme capable of synthesizing poly alpha-1,3-glucan with water, sucroseand a polar organic solvent in a solution. The glucosyltransferaseenzyme used herein catalyzes the conversion of sucrose to polyalpha-1,3-glucan. An example of such a glucosyltransferase enzyme iswild type gtfJ expressed by Streptococcus salivarius (GENBANKIdentification No. 47527, SEQ ID NO:18; Simpson et al., Microbiology141:1451-1460, 1995). U.S. Pat. No. 7,000,000 (incorporated herein byreference) discloses using a particular gtfJ derived from S. salivariusto produce a poly alpha-1,3-glucan that is suitable for use as aspinnable fiber.

Any glucosyltransferase enzyme may be used in the process of theinvention disclosed herein. Preferably, the enzyme is fungal orbacterial. Such an enzyme may be derived from a Streptococcus species,Leuconostoc species or Lactobacillus species, for example. Examples ofStreptococcus species from which the glucosyltransferase may be derivedinclude S. salivarius, S. sobrinus, S. dentirousetti, S. downei, S.mutans, S. oralis and S. sanguinis. Examples of Leuconostoc species fromwhich the glucosyltransferase may be derived include L. mesenteroides,L. amelibiosum, L. argentinum, L. carnosum, L. citreum, L. cremoris, L.dextranicum and L. fructosum. Examples of Lactobacillus species fromwhich the glucosyltransferase may be derived include L. acidophilus, L.delbrueckii, L. helveticus, L. salivarius, L. casei, L. curvatus, L.plantarum, L. sakei, L. brevis, L. buchneri, L. fermentum and L.reuteri.

The glucosyltransferase enzyme used in certain embodiments of theinvention comprises, or consists of, the amino acid sequence provided inSEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ IDNO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ IDNO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, or SEQ IDNO:32. Alternatively, the glucosyltransferase enzyme comprises, orconsists of, an amino acid that is at least 90%, 91%, 92%, 93%, 94%,95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ IDNO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14, SEQ IDNO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ IDNO:26, SEQ ID NO:28, SEQ ID NO:30, or SEQ ID NO:32, wherein theglucosyltransferase enzyme has activity. The glucosyltransferase enzymeused in certain embodiments comprises an amino acid sequence that is atleast 90% identical to the sequence set forth in SEQ ID NO:12, SEQ IDNO:2, or SEQ ID NO:32. In still another aspect, a glucosyltransferaseenzyme may be any of the above-identified amino acid sequences andfurther include 1-300 (or any integer there between) residues on theN-terminus and/or the C-terminus and still retain activity. Suchadditional residues may be from a corresponding wild type sequence fromwhich the glucosyltransferase enzyme is derived, or may be anothersequence such as an epitope tag (at either N- or C-terminus) or aheterologous signal peptide (at N-terminus), for example.

In another aspect a glucosyltransferase enzyme could be a variantenzyme, i.e., one that is non-naturally occurring but retains activity.For example, it could be modified through a truncation or a deletion.Such a variant enzyme may lack a number of amino acids at the N- and/orC-terminus (truncation or internal deletion) compared to the wild typesequence from which the variant enzyme was derived. For example, aglucosyltransferase enzyme used herein may lack amino acids in thesignal peptide and/or variable domain that are otherwise present in thecorresponding wild type form of the enzyme. This is an example of anenzyme with an N-terminal truncation or internal deletion. As anotherexample, a glucosyltransferase enzyme used in the instant process maylack amino acids in the glucan-binding domain. This is an example of anenzyme with a C-terminal truncation or internal deletion. Other examplesof enzymes that can be used are those having both N- and C-terminaltruncations or deletions. All the various modified glucosyltransferaseenzymes disclosed herein, such as the above-described truncated andinternally deleted variants, have glucosyltransferase activity.

The glucosyltransferase enzyme in certain embodiments is encoded by thepolynucleotide sequence provided in SEQ ID NO:1, SEQ ID NO:3, SEQ IDNO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ IDNO:15, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:23, SEQ ID

NO:25, SEQ ID NO:27, SEQ ID NO:29, or SEQ ID NO:31. Alternatively, theglucosyltransferase enzyme is encoded by a polynucleotide sequence thatis at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%identical to SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ IDNO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17, SEQ IDNO:19, SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ IDNO:29, or SEQ ID NO:31.

The glucosyltransferase enzyme in certain embodiments synthesizes polyalpha-1,3-glucan in which at least about 50%, 60%, 70%, 80%, 90%, 95%,96%, 97%, 98%, 99%, or 100% (or any integer between 50% and 100%) of theconstituent glycosidic linkages are alpha-1,3 linkages. In suchembodiments, accordingly, the glucosyltransferase enzyme synthesizespoly alpha-1,3-glucan in which there is less than about 50%, 40%, 30%,20%, 10%, 5%, 4%, 3%, 2%, or 1% of glycosidic linkages that are notalpha-1,3. Examples of such non-alpha-1,3 glycosidic linkages includebeta linkages (e.g., beta-1,2; beta-1,3; beta-1,4; beta-1,6) and otheralpha linkages (e.g., alpha-1,2; alpha-1,4; alpha-1,6).

In other aspects, the glucosyltransferase enzyme synthesizes polyalpha-1,3-glucan with no branch points or less than about 10%, 9%, 8%,7%, 6%, 5%, 4%, 3%, 2%, or 1% branch points as a percent of theglycosidic linkages in the polymer. Examples of branch points includealpha-1,6 branch points, such as those that are present in mutanpolymer.

One or more different glucosyltransferase enzymes may be used in thesolution in which the enzyme is contacted with water, sucrose and apolar organic solvent. The glucosyltransferase enzyme in certainembodiments does not have, or has very little (less than 1%),dextransucrase, reuteransucrase, or alternansucrase activity. Theglucosyltransferase enzyme in certain embodiments does not produce, orproduces very few (less than 1% or 2%), glycosidic linkages that are notalpha-1,3 glycosidic linkages. Nor is the glucosyltransferase a wildtype enzyme derived from S. mutans in certain embodiments.

The glucosyltransferase enzyme used in the instant process can beprimer-independent or primer-dependent. A primer-dependentglucosyltransferase enzyme requires the presence of an initiatingmolecule in the reaction solution to act as a primer for the enzymeduring glucan polymer synthesis. The term “primer” as used herein refersto any molecule that can act as the initiator for a glucosyltransferaseenzyme. Primer-independent glucosyltransferase enzymes do not requirethe presence of a primer to perform glucan synthesis. Primers that canbe used in certain embodiments include dextran and othercarbohydrate-based primers, such as hydrolyzed glucan.

The glucosyltransferase enzyme used herein may be produced by any meansknown in the art (e.g., U.S. Pat. No. 7,000,000, which is incorporatedherein by reference). For example, the glucosyltransferase enzyme may beproduced recombinantly in any bacterial (e.g., E. coli such as TOP10,Bacillus sp.) or eukaryotic (e.g., yeasts such as Pichia sp. andSaccharomyces sp.) heterologous gene expression system. One of theabove-listed nucleic acid sequences can be used for this purpose, forexample. Alternatively, the glucosyltransferase enzyme may be obtainedfrom a species that naturally produces a glucosyltransferase enzyme.

The glucosyltransferase enzyme used herein may be purified and/orisolated prior to its use, or may be used in the form of a cell lysate,for example. A cell lysate or extract may be prepared from a bacteria(e.g., E. coli) used to heterologously express the enzyme. For example,the bacteria may be subjected to disruption using a French pressure cell(French press). The glucosyltransferase enzyme is soluble in these typeof preparations. The lysate or extract may be used at about 0.15-0.3%(v/v) in a reaction solution for producing poly alpha-1,3-glucan fromsucrose. In certain embodiments, a bacterial cell lysate is firstcleared of insoluble material by means such as centrifugation orfiltration.

In certain embodiments, the heterologous gene expression system may beone that is designed for protein secretion. The glucosyltransferaseenzyme comprises a signal peptide (signal sequence) in such embodiments.The signal peptide may be either its native signal peptide or aheterologous signal peptide.

The activity of the glucosyltransferase enzyme can be determined usingany method known in the art. For example, glucosyltransferase enzymeactivity can be determined by measuring the production of reducingsugars (fructose and glucose) in a reaction solution containing sucrose(50 mg/mL), dextran T-10 (1 mg/mL) and potassium phosphate buffer (pH6.5, 50 mM), where the solution is held at 22-25° C. for 24-30 hours.The reducing sugars can be measured by adding 0.01 mL of the reactionsolution to a mixture containing 1 N NaOH and 0.1% triphenyltetrazoliumchloride and then monitoring the increase in absorbance at OD_(480 nm)for five minutes.

A polar organic solvent is used in the disclosed process. The polarorganic solvent can be aprotic. Examples of aprotic polar organicsolvents that can be used include, but are not limited to, acetonitrile,dimethyl sulfoxide, acetone, N,N-dimethylformamide,N,N-dimethylacetamide, tetrahydrofuran, propylene carbonate, andsulfolane. Other non-limiting examples of aprotic polar organic solventsthat can be used include hexamethylphosphoramide,dimethylimidazolidinone (1,3-dimethyl-2-imidazolidinone), dioxane,nitromethane, and butanone. In general, ester, ketone and aldehydesolvents having no acidic hydrogen atom are other examples of aproticpolar organic solvents that can be used. Acetonitrile can be used as apreferred polar organic solvent.

The polar organic solvent can be protic. Examples of protic polarorganic solvents that can be used include, but are not limited to,methanol, methyl formamide, ethanol, isopropanol, 1-propanol, tert-butylalcohol, and formamide. Other non-limiting examples of protic polarorganic solvents that can be used include n-butanol, ethylene glycol,2-methoxyethanol, 1-methoxy-2-propanol, glycerol, 1,2-propanediol and1,3-propanetriol. In general, alcohols are other examples of proticpolar organic solvents that can be used.

One or more polar organic solvents, such as any of those listed above,may be used in performing the disclosed process. In certain embodiments,the concentration of the polar organic solvent in the solution is about2% to about 20% by volume. The concentration of the polar organicsolvent in the solution is about 10% by volume in certain embodiments.Alternatively, the concentration of the polar organic solvent in thesolution can be about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%,13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, or 25% byvolume. Where two or more polar organic solvents are used, their totalconcentration may be any of the above volume percent measurements.

The temperature of the reaction solution in which the water, sucrose,polar organic solvent and glucosyltransferase enzyme are contacted canbe controlled, if desired. In certain embodiments, the solution has atemperature between about 5° C. to about 50° C. The temperature of thesolution in certain other embodiments is between about 20° C. to about40° C. Alternatively, the temperature of the solution may be about 20,21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38,39, or 40° C.

The temperature of the reaction solution may be maintained using variousmeans known in the art. For example, the temperature of reactionsolution can be maintained by placing the vessel containing the reactionsolution in an air or water bath incubator set at the desiredtemperature.

The initial concentration of the sucrose in the solution can be about 20g/L to about 400 g/L, for example. Alternatively, the initialconcentration of the sucrose can be about 75 g/L to about 175 g/L.Alternatively still, the initial concentration of the sucrose can beabout 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145,150, 155, or 160 g/L. The “initial concentration of sucrose” refers tothe sucrose concentration in the solution after all the reactionsolution components have been added (water, sucrose, gtf enzyme).

Sucrose used in the reaction solution can be highly pure (≧99.5%) or beof any other purity or grade. For example, the sucrose can have a purityof at least 99.0%, or be reagent grade sucrose. The sucrose may bederived from any renewable sugar source such as sugar cane, sugar beets,cassava, sweet sorghum, or corn. The sucrose can be provided in any formsuch as crystalline form or non-crystalline form (e.g., syrup or canejuice).

The pH of the solution in which the water, sucrose, polar organicsolvent and glucosyltransferase are contacted can be between about 4.0to about 8.0 in certain embodiments. Alternatively, the pH can be about4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, or 8.0. In certain embodiments,the pH of a solution containing the water, sucrose and polar organicsolvent may be set before adding the glucosyltransferase enzyme. The pHof the reaction solution can be adjusted or controlled by the additionor incorporation of a suitable buffer, including but not limited to:phosphate, tris, citrate, or a combination thereof. The concentration ofthe buffer can be from 0 mM to about 100 mM, for example. In certainembodiments, the buffer concentration is about 10, 20, or 50 mM. Asuitable amount of DTT (e.g., about 1.0 mM) may also be added to thereaction solution in certain embodiments.

Water, sucrose, a polar organic solvent and a glucosyltransferase enzymeare contacted in a reaction solution. It will be understood that, as theglucosyltransferase enzyme synthesizes poly alpha-1,3-glucan, thereaction solution becomes a reaction mixture given that insoluble polyalpha-1,3-glucan falls out of solution as indicated by clouding of thereaction. The contacting step of the disclosed process can be performedin any number of ways. For example, the desired amounts of sucrose andpolar organic solvent can first be dissolved in water (optionally, othercomponents may also be added at this stage of preparation, such asbuffer components), followed by the addition of the glucosyltransferaseenzyme. The solution may be kept still, or agitated via stirring ororbital shaking, for example. The reaction can be, and typically is, acell-free.

The glucosyltransferase enzyme can be added to water or an aqueoussolution (e.g., sucrose in water; sucrose and polar organic solvent inwater) that does not contain salt or buffer when initially preparing thereaction solution. The pH of such a preparation can then be modified asdesired, such as to pH 5-6 for example. The reaction can be carried outto completion without any added buffer, if desired.

Completion of the reaction in certain embodiments can be determinedvisually (no more accumulation of precipitated poly alpha-1,3-glucan)and/or by measuring the amount of sucrose left in the solution (residualsucrose), where a percent sucrose consumption of over about 90% canindicate reaction completion. Typically, a reaction of the disclosedprocess will take about 12, 24, 36, 48, 60, 72, 84, or 96 hours tocomplete, depending on certain parameters such as the amount of sucroseand glucosyltransferase enzyme used in the reaction.

The percent sucrose consumption of a reaction in certain embodiments ofthe disclosed process is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%,97%, 98%, 99%, or 100%. Alternatively, the percent sucrose consumptionmay be >90% or >95%.

In certain embodiments of the disclosed process, the polar organicsolvent does not significantly reduce the activity of theglucosyltransferase enzyme in terms of the percent sucrose consumedduring the reaction. This is the case, for example, in reactions wherethe percent sucrose consumed at the completion of the reaction is atleast 90% or 95%.

The inclusion of a polar organic solvent in the disclosed processresults in reducing the molecular weight of the poly alpha-1,3-glucanproduced by a glucosyltransferase enzyme. Another way to reduce themolecular weight in certain embodiments is to increase the reactiontemperature. In certain embodiments of the disclosed process, the polarorganic solvent enhances such temperature-dependent reduction in polyalpha-1,3-glucan molecular weight. Such enhancement can be at leastabout 5%, 10%, 15%, 20%, 25%, 30%, 35%, or 40% (or any integer between5% and 40%) more reduction of molecular weight of poly alpha-1,3-glucanproduced in the process containing a polar organic solvent compared tothat produced in a corresponding or control process lacking the polarorganic solvent. Any of the glucosyltransferase enzymes and polarorganic solvents disclosed herein may be used in this aspect of thedisclosed process. For example, gtfJ (SEQ ID NO:2) and acetonitrile(e.g., 10 vol %) may be used. The increase in temperature can be byabout 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14° C. in certainembodiments (e.g., from 25° C. to 37° C.).

The poly alpha-1,3-glucan produced in the disclosed process mayoptionally be isolated. For example, insoluble poly alpha-1,3-glucan maybe separated by centrifugation or filtration. In doing so, the polyalpha-1,3-glucan is separated from the rest of the reaction solution,which may comprise water, fructose and certain byproducts (e.g.,leucrose, soluble oligosaccharides DP2-DP7). This solution may alsocomprise residual sucrose and glucose monomer.

Poly alpha-1,3 glucan is a potentially low cost polymer which can beenzymatically produced from renewable resources containing sucrose usingglucosyltransferase enzymes. It has been shown that this polymer canform ordered liquid crystalline solutions when the polymer is dissolvedin a solvent under certain conditions (U. S. Pat. No. 7,000,000). Suchsolutions can be spun into continuous, high strength, cotton-likefibers. The poly alpha-1,3 glucan produced using the instant process hascomparable utilities. In addition, the poly alpha-1,3 glucan producedherein can be derivatized as described in U.S. Pat. Appl. Publ. Nos. 2014/01 7991 3 and 2014/0187767, which are both incorporated herein byreference.

EXAMPLES

The disclosed invention is further defined in the following Examples. Itshould be understood that these Examples, while indicating certainpreferred aspects of the invention, are given by way of illustrationonly. From the above discussion and these Examples, one skilled in theart can ascertain the essential characteristics of this invention, andwithout departing from the spirit and scope thereof, can make variouschanges and modifications of the invention to adapt it to various usesand conditions.

Abbreviations

The meaning of some of the abbreviations used herein is as follows: “g”means gram(s), “h” means hour(s), “mL” means milliliter(s), “psi” meanspound(s) per square inch, “wt %” means weight percentage, “pm” meansmicrometer(s), “%” means percent, “° C.” means degrees Celsius, “mg”means milligram(s), “mm” means millimeter(s), “mL/min” means millilitersper minute, “m” means meter(s), “μL” means microliter(s), “mmol” meansmillimole(s), “min” means minute(s), “mol %” means mole percent, “M”means molar, “mg/g” means milligram per gram, “rpm” means revolutionsper minute, “MPa” means megaPascals.

General Methods

All reagents were obtained from Sigma-Aldrich (St. Louis, Mo.) unlessstated otherwise. N,N-Dimethylacetamide was obtained from J. T. Baker(Phillipsburg, N.J.). Sucrose was obtained from VWR (Radnor, Pa.).

Preparation of Crude Extracts of Glucosyltransferase (gtf) Enzymes

The Streptococcus salivarius gtfJ enzyme (SEQ ID NO:2) used in Examples1 and 2 was expressed in E. coli strain DH10B using an isopropylbeta-D-1-thiogalactopyranoside (IPTG)-induced expression system. SEQ IDNO:2 has an N-terminal 42-residue deletion compared to the S. salivariusgtfJ amino acid sequence in GENBANK Identification No. 47527. Briefly,E. coli DH10B cells were transformed to express SEQ ID NO:2 from a DNAsequence (SEQ ID NO:1) codon-optimized to express the gtfJ enzyme in E.coli. This DNA sequence was contained in the expression vector,pJexpress404® (DNA 2.0, Menlo Park Calif.). The transformed cells wereinoculated to an initial optical density (OD at 600_(nm)) of 0.025 in LBmedium (10 g/L Tryptone; 5 g/L yeast extract, 10 g/L NaCl) and allowedto grow at 37° C. in an incubator while shaking at 250 rpm. The cultureswere induced by addition of 1 mM IPTG when they reached an OD₆₀₀ of0.8-1.0. Induced cultures were left on the shaker and harvested 3 hourspost induction.

GtfJ enzyme (SEQ ID NO:2) was harvested by centrifuging cultured cells(25° C., 16,000 rpm) in an Eppendorf° centrifuge, re-suspending thecells in 5.0 mM phosphate buffer (pH 7.0) and cooling to 4° C. on ice.The cells were broken using a bead beater with 0.1-mm silica beads, andthen centrifuged at 16,000 rpm at 4° C. to pellet the unbroken cells andcell debris. The crude extract (containing soluble gtfJ enzyme, SEQ IDNO:2) was separated from the pellet and analyzed by Bradford proteinassay to determine protein concentration (mg/m L).

The gtf enzymes used in Example 3 were prepared as follows. E. coliTOP10° cells (Invitrogen, Carlsbad Calif.) were transformed with apJexpress404®-based construct containing a particular gtf-encoding DNAsequence. Each sequence was codon-optimized to express the gtf enzyme inE. coli. Individual E. coli strains expressing a particular gtf enzymewere grown in LB medium with ampicillin (100 μg/mL) at 37° C. withshaking to OD₆₀₀=0.4-0.5, at which time IPTG was added to a finalconcentration of 0.5 mM. The cultures were incubated for 2-4 hours at37° C. following IPTG induction. Cells were harvested by centrifugationat 5,000×g for 15 minutes and resuspended (20% w/v) in 50 mM phosphatebuffer pH 7.0 supplemented with dithiothreitol (DTT, 1.0 mM).Resuspended cells were passed through a French Pressure Cell (SLMInstruments, Rochester, N.Y.) twice to ensure >95% cell lysis. Lysedcells were centrifuged for 30 minutes at 12,000×g at 4° C. The resultingsupernatant was analyzed by the BCA protein assay and SDS-PAGE toconfirm expression of the gtf enzyme, and the supernatant was stored at−20° C.

Analysis of Reaction Profiles

Periodic samples from reactions were taken and analyzed using anAgilent® 1260 HPLC equipped with a refractive index detector. An Aminex®HP-87C column (BioRad, Hercules, Calif.) having deionized water at aflow rate of 0.6 mL/min and 85° C. was used to quantitate the level ofsucrose, glucose, leucrose and fructose in the reaction mixtures. AnAminex® HP-42A column (BioRad) having deionized water at a flow rate of0.6 mL/min and 85° C. was used to quantitate soluble oligosaccharidebyproducts (DP2-DP7).

Analysis of Glucan Molecular Weight

Insoluble glucan polymer isolated from reaction mixtures was treatedwith N,N-dimethylacetamide (DMAc) with 5% lithium chloride (LiCI) at100° C. for 16 hours to form a glucan polymer solution. This solution(100 μL) was then injected into an Alliance™ 2695 HPLC (WatersCorporation, Milford, Mass.) equipped with a differential refractometerdetector operating at 50° C. The mobile phase (DMAc containing 0.11 wt %LiCl) passed at a flow rate of 0.5 mL/min through four styrene-divinylbenzene columns in series; specifically, one KD-802, one KD-801, and twolinear KD-806M columns (Shodex, Japan). The polymer molecular weightdistribution of the glucan polymer sample was determined by comparisonof retention time to a broad glucan standard.

Example 1 Glucan Polymerization Reactions Using gtfJ Enzyme and PolarOrganic Solvents

This Example describes producing alpha-1,3-glucan in gtf-catalyzedreactions containing polar organic solvent. Specifically, this exampleshows that including a polar organic solvent (10 vol %) in a gtfreaction solution reduces the molecular weight of alpha-1,3-glucansynthesized by the reaction. The gtf in this Example was the S.salivarius gtfJ enzyme (SEQ ID NO:2).

The desired amount of sucrose was weighed out and diluted up to 90 mLusing deionized water. 10 mL of either a polar organic solvent (seeTable 2) or water (control) was then added to bring the total volume to100 mL. The polar organic solvent used was methanol, methyl formamide,ethanol, DMSO, i-propanol, t-butanol, n-propanol, acetone, formamide,acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide,tetrahydrofuran, propylene carbonate, or sulfolane. Each solution wasnext transferred to a 125-mL glass bottle equipped with a polypropylenecap. Fermasure™ was then added (0.5 mL/L reaction, which is 500 ppm),and the pH was adjusted to 5.5 using 5 wt % aqueous sodium hydroxide or5 wt % aqueous sulfuric acid. The glucan polymerization reaction wasinitiated by adding 0.3 vol % of crude gtf enzyme (SEQ ID NO:2) extractprepared as described in the General Methods section. This extractcontained about 2.9 mg/mL of protein. Agitation to the reaction solutionwas provided using an Innova® 42 incubator shaker controlled at 25° C.The reaction solution was periodically monitored by HPLC as described inthe General Methods section.

After the reaction was determined to be complete by either completeconsumption of sucrose or no change in sucrose concentration betweenmeasurements, the reaction slurry was filtered. The insolublealpha-1,3-glucan polymer was then washed with water (200 mL) and acetone(50 mL) and dried at 105° C. using a heated balance (Mettler Toledo®HG63) until no mass change was observed.

The polymer molecular weight was measured according to the GeneralMethods and is presented as the degree of polymerization based on weight(DPw, also referred to as “weight average degree of polymerization”),which can be calculated as the average polymer molecular weight dividedby the monomer molecular weight. The results of the polymerizationreactions are provided in Table 2. In all cases, a lower polymermolecular weight was observed for reactions in which a polar organicsolvent was included, as compared to the molecular weight of the polymerproduced by the pure aqueous reaction.

TABLE 2 Molecular Weight of alpha-1,3-Glucan Polymer Produced inReaction Solutions Containing 10 Vol % Organic Solvent % Sucrose Final %Initial sucrose consumption Sucrose Reaction Solvent DPw (g/L) after 24hr consumption time (hr) Water only 714 100 96 96 24 Methanol 594 98 9494 96 Methyl formamide 519 111 39 40 48 Ethanol 518 98 93 95 96 DMSO 46298 ND^(a) 95 65 i-propanol 431 98 82 96 43 t-butanol 424 109 95 96 96n-propanol 374 98 86 95 96 Acetone 358 99 72 96 44 Formamide 329 103 6397 67 Acetonitrile 321 100 >95   >95 28 N,N-dimethylformamide 313 102 8295 88 N,N-dimethylacetamide 304 99 71 92 44 Tetrahydrofuran 286 101 7296 44 Propylene carbonate 260 99 57 90 88 Sulfolane 236 98 75 95 48^(a)Not determined.

The data in Table 2 indicate that the inclusion of a polar organicsolvent (10 vol %) in the gtf reaction solution reduced the DPw of thealpha-1,3-glucan polymer produced in the reaction. This reduction was ascompared to the DPw of the polymer produced in the control reaction inwhich no polar organic solvent was added (water only). The DPwreductions observed ranged from about 17% (when methanol was used) toabout 67% (when sulfolane was used). In almost every case (except wherethe added polar organic solvent was methyl formamide), over 90% of thesucrose supplied in each reaction was consumed, indicating that theadded polar organic solvent generally did not inhibit completeconsumption of sucrose. Furthermore, since many of the solvent systemshad sucrose conversion after 24 hours similar to the sucrose conversionof the pure aqueous system (Table 2), but lower polymer DPw, differencesin polymer DPw cannot necessarily be attributed to enzyme activity.

Table 2 also indicates that both protic and aprotic polar organicsolvents were useful in gtf reaction solutions to reduce the DPw of thealpha-1,3-glucan polymer produced in the reaction. The protic polarorganic solvents were methanol, methyl formamide, ethanol, i-propanol(isopropanol), n-propanol (1-propanol), t-butanol (tert-butyl alcohol),and formamide, whereas the aprotic polar organic solvents were DMSO(dimethyl sulfoxide), acetone, acetonitrile, N,N-dimethylformamide,N,N-dimethylacetamide, tetrahydrofuran, propylene carbonate, andsulfolane. In general, aprotic polar organic solvents were moreeffective at reducing polymer DPw when added to the reaction compared toprotic polar organic solvents (Table 2). Most of the gtf reactions towhich an aprotic polar organic solvent was added produced glucan polymerwith a DPw that was reduced by more than 50% compared to the glucanpolymer produced in the completely aqueous gtf reaction.

Thus, the addition of a polar organic solvent to a gtf reaction solutionreduces the molecular weight of the alpha-1,3-glucan polymer product ofthe reaction.

Example 2 Glucan Polymerization Reactions Using qtfJ Enzyme andAcetonitrile

This Example describes producing alpha-1,3-glucan in gtf-catalyzedreactions containing the aprotic polar organic solvent, acetonitrile.Specifically, this example shows that increasing levels of acetonitrilelead to greater reductions in polymer molecular weight, and thatacetonitrile can reduce the molecular weight of polymer produced inreactions at 37° C.

The procedure described in Example 1 was followed to prepare S.salivarius gtfJ (SEQ ID NO:2) reaction solutions containingacetonitrile. However, the amount of acetonitrile added to the reactionsolution was varied from 2-20 mL (for 2, 10, or 20 vol % acetonitrile);the amount of water was adjusted accordingly to maintain a totalreaction volume of 100 mL. The results of these reactions are providedin Table 3.

TABLE 3 Molecular Weight of alpha-1,3-Glucan Polymer Produced inReaction Solutions Containing Various Amounts of Acetonitrile InitialTemperature Volume % sucrose % Sucrose (° C.) Acetonitrile DPw (g/L)consumption 25 0 714 106 96 25 2 702 100 96 25 10 321 100 >95 25 20 186101 63

As indicated in Table 3, increasing the amount of acetonitrile in thegtf reaction resulted in greater reductions in the alpha-1,3-glucanpolymer molecular weight. These results indicate that glucan polymermolecular weight can be controlled by varying the concentration of theadded polar organic solvent.

Next, the procedure described in Example 1 was followed to prepare gtfreaction solutions containing acetonitrile, with the exception that thetemperature of the reaction was 37° C. (as opposed to 25° C.). Theresults of these reactions are provided in Table 4.

TABLE 4 Molecular Weight of alpha-1,3-Glucan Polymer Produced at 37° C.in Reaction Solutions Containing Acetonitrile Initial Temperature Volume% sucrose % Sucrose (° C.) Acetonitrile DPw (g/L) consumption 37 0 49296 97 37 10 187 98 94

As indicated in Table 4, performing the glucan polymerization reactionwith acetonitrile at 37° C. led to the production of polymer withreduced molecular weight. As can be seen by comparing the results inTables 3 and 4 for gtf reaction solutions containing 10 vol %acetonitrile, raising the reaction temperature from 25° C. to 37° C. ledto enhanced reduction of the molecular weight of the alpha-1,3-glucanproduct (from a DPw of 321 at 25° C. to a DPw of 187 at 37° C.). Thepercent sucrose consumption was over 90% in both the 25° C. and 37° C.reactions.

Table 4 indicates that gtf reaction solutions that were completelyaqueous (no polar organic solvent added) also produced polymer withreduced molecular weight, when compared to the same reaction performedat 25° C. Specifically, the DPw of 492 obtained in the 37° C. reactionwas lower than the DPw of 714 obtained in the 25° C. reaction (Table 3);this represents a reduction in polymer molecular weight by about 31%. Incontrast, the reduction in polymer molecular weight observed between the25° C. and 37° C. reactions containing 10 vol % acetonitrile was about42%. The inclusion of a polar organic solvent therefore can enhance thereduction in polymer molecular weight observed when increasing reactiontemperature.

Example 3 Glucan Polymerization Reactions Using Various gtf Enzymes

This Example describes producing alpha-1,3-glucan in reactionscontaining a polar organic solvent and different gtf enzymes.Specifically, this example shows that, in addition to SEQ ID NO:2, othertypes of gtf enzymes can be used in reactions containing acetonitrile toproduce glucan polymer with reduced molecular weight.

The gtf enzymes used in this example were as follows:

The S. salivarius gtfJ enzyme was SEQ ID NO:2, encoded by SEQ ID NO:1.

An N-terminally truncated version of a Streptococcus sobrinus gtf enzymeidentified in GENBANK under GI number 450874 was used (SEQ ID NO:4,encoded by SEQ ID NO:3; herein referred to as “0874”).

An N-terminally truncated version of Streptococcus salivarius K12 gtfenzyme identified in GENBANK as a dextransucrase under GI number400182678 was used (SEQ ID NO:6, encoded by SEQ ID NO:5; herein referredto as “2678”).

An N-terminally truncated version of Streptococcus salivarius PS4 gtfenzyme identified in GENBANK as a putative glucosyltransferase under GInumber 383282919 was used (SEQ ID NO:8, encoded by SEQ ID NO:7; hereinreferred to as “2919”).

An N-terminally truncated version of Streptococcus dentirousetti gtfenzyme identified in GENBANK under GI number 167735926 was used (SEQ IDNO:10, encoded by SEQ ID NO:9; herein referred to as “5926”).

An N-terminally truncated version of Streptococcus salivarius SK126 gtfenzyme identified in GENBANK under GI number 228476855 was used (SEQ IDNO:12, encoded by SEQ ID NO:11; herein referred to as “6855”).

Another version of the S. salivarius gtfJ enzyme used in this study wasSEQ ID NO:14 (herein referred to as “gtfJ-T1”). SEQ ID NO:14, comparedto the amino acid sequence identified in GENBANK under GI number 47527,is truncated by 230 amino acids at the N-terminus and 384 amino acids atthe C-terminus. As with the other gtf enzymes disclosed herein, SEQ IDNO:14 was produced using a DNA that was codon-optimized for expressionin E. coli. SEQ ID NO:13 (Table 1), which is representative of asequence encoding SEQ ID NO:14, was not used for enzyme expression sinceit is not codon-optimized.

Another version of the S. dentirousetti gtf enzyme used in this studywas SEQ ID NO:16 (herein referred to as “5926-T1”). SEQ ID NO:16,compared to the amino acid sequence identified in GENBANK under GInumber 167735926, is truncated by 199 amino acids at the N-terminus and417 amino acids at the C-terminus. As with the other gtf enzymesdisclosed herein, SEQ ID NO:16 was produced using a DNA that wascodon-optimized for expression in E. coli. SEQ ID NO:15 (Table 1), whichis representative of a sequence encoding SEQ ID NO:16, was not used forenzyme expression since it is not codon-optimized.

The procedure described in Example 1 was followed to prepare reactionsolutions containing a particular gtf (see Table 5) and acetonitrile (10vol %). The reactions were performed at 25° C. and the alpha-1,3-glucanproduced in each reaction was analyzed for DPw. The results are providedin Table 5.

TABLE 5 Molecular Weight of alpha-1,3-Glucan Polymer Produced inReaction Solutions Containing Various gtf Enzymes Initial % Sucrose gtfsucrose con- Enzyme SEQ ID NO Solvent^(a) DPw (g/L) sumption 0874 SEQ IDNO: 4 Acetonitrile 52 149 97 None 56 143 90 2678 SEQ ID NO: 6Acetonitrile 283 149 65 None 657 151 93 2919 SEQ ID NO: 8 Acetonitrile188 149 94 None 414 152 91 5926 SEQ ID NO: 10 Acetonitrile 57 149 74None 68 149 96 5926-T1 SEQ ID NO: 16 Acetonitrile 70 149 97 None 108 150100 6855 SEQ ID NO: 12 Acetonitrile 247 149 96 None 571 151 96 gtfJ SEQID NO: 2 Acetonitrile 305 150 71 None 577 151 96 gtfJ-T1 SEQ ID NO: 14Acetonitrile 252 149 96 None 495 142 94 ^(a)Solvent was completelyaqueous (None) or contained 10 vol % acetonitrile (Acetonitrile).

As indicated in Table 5, all the different gtf enzymes producedalpha-1,3-glucan polymer having a reduced molecular weight when used ina reaction solution containing a polar organic solvent (10 vol %acetonitrile), compared to when the enzymes were used in purely aqueouscontrol reactions. All but one of the gtf reactions yielded glucanpolymer with a DPw that was reduced by at least 15%.

Most of the reactions containing acetonitrile consumed over 90% of thesucrose supplied in the reaction (Table 5), indicating that the addedacetonitrile generally did not inhibit gtf enzyme activity. In certainreactions (gtfs 0874, 2919, 6855, gtfJ-T1), the addition of acetonitrileresulted in sucrose consumption that was equal to or greater than thesucrose consumption that occurred in the purely aqueous reaction.

Table 5 also indicates that the addition of acetonitrile in a gtfreaction reduced the molecular weight of the alpha-1,3-glucan polymerproduced regardless of the polymer size generally produced by the gtf.For example, even though gtf enzymes 0874 (SEQ ID NO:4) and 6855 (SEQ IDNO:12) produced glucan polymers of 56 and 571 DPw, respectively, inpurely aqueous reaction conditions, both enzymes produced polymer withreduced DPw in reactions containing acetonitrile.

Table 5 also indicates that the addition of acetonitrile in a gtfreaction reduced the molecular weight of the alpha-1,3-glucan polymerproduced regardless of the size of the gtf. Specifically, both enzymesgtfJ (SEQ ID NO:2) and its shortened counterpart gtfJ-T1 (SEQ ID NO:14)produced glucan polymer with reduced DPw when acetonitrile was includedin the reaction. This was similarly the case with gtf enzymes 5926 (SEQID NO:10) and 5926-T1 (SEQ ID NO:16).

Thus, various types of gtf enzymes can be used in reactions containing apolar organic solvent to produce alpha-1,3-glucan polymer with reducedmolecular weight. Given that all of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14and 16 produced alpha-1,3-glucan polymer with reduced molecular weightin reaction solutions containing a polar organic solvent, other gtfenzymes such as SEQ ID NOs:18, 20, 22, 24, 26, 28, 30 and 32 could beused in a similar manner to produce alpha-1,3-glucan polymer withreduced molecular weight.

What is claimed is:
 1. A process for producing poly alpha-1,3-glucancomprising: a) contacting water, sucrose, a polar organic solvent, and aglucosyltransferase enzyme in a solution, wherein a polyalpha-1,3-glucan is produced having a reduced molecular weight comparedto the molecular weight of a poly alpha-1,3-glucan produced in theabsence of the polar organic solvent; and b) optionally, isolating thepoly alpha-1,3-glucan produced in step (a).
 2. The process of claim 1,wherein the polar organic solvent is aprotic.
 3. The process of claim 2,wherein the polar organic solvent is selected from the group consistingof acetonitrile, dimethyl sulfoxide, acetone, N,N-dimethylformamide,N,N-dimethylacetamide, tetrahydrofuran, propylene carbonate, andsulfolane.
 4. The process of claim 1, wherein the polar organic solventis protic.
 5. The process of claim 4, wherein the polar organic solventis selected from the group consisting of methanol, methyl formamide,ethanol, isopropanol, 1-propanol, tert-butyl alcohol, and formamide. 6.The process of claim 1, wherein the concentration of the polar organicsolvent in the solution is about 2% to about 20% by volume.
 7. Theprocess of claim 6, wherein the concentration of the polar organicsolvent in the solution is about 10% by volume.
 8. The process of claim1, wherein the solution has a temperature between about 5° C. to about50° C.
 9. The process of claim 1, wherein the initial concentration ofthe sucrose in the solution is about 20 g/L to about 400 g/L.
 10. Theprocess of claim 1, wherein the molecular weight of the polyalpha-1,3-glucan produced in step (a) is reduced by at least about 15%.11. The process of claim 1, wherein the molecular weight of the polyalpha-1,3-glucan produced in step (a) is reduced by at least about 50%.12. The process of claim 1, wherein the molecular weight is measured asweight average degree of polymerization (DPw).
 13. The process of claim12, wherein the DPw of the poly alpha-1,3-glucan produced in step (a) isbetween about 40 and
 800. 14. The process of claim 1, wherein theglucosyltransferase enzyme is a bacterial glucosyltransferase enzyme.15. The process of claim 1, wherein the glucosyltransferase enzymecomprises an amino acid sequence that is at least 90% identical to SEQID NO:12, SEQ ID NO:2, or SEQ ID NO:32.